B-cell Lymphoma
Showing 76 - 95 of 95
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in Beijing (PZ01 CAR-T cells)
Unknown status
- B-cell Acute Lymphoblastic Leukemia
- B-cell Lymphoma
- PZ01 CAR-T cells
-
Beijing, Beijing, ChinaDepartment of Hematology, Navy General Hospital of PLA
Sep 14, 2017
B-cell Lymphoma Trial in Worldwide (Bevacizumab, Rituximab, CHOP)
B-cell Lymphoma, Indolent B-cell Lymphoma Trial in Boston (rituximab)
Completed
- B-cell Lymphoma
- Indolent B-cell Lymphoma
-
Boston, Massachusetts
- +1 more
May 9, 2017
B-Cell Leukemia, B-Cell Lymphoma Trial in Shijiazhuang (Autologous CD19-targeting CAR T cells)
Unknown status
- B-Cell Leukemia
- B-Cell Lymphoma
- Autologous CD19-targeting CAR T cells
-
Shijiazhuang, Hebei, ChinaNo.2 Hospital of Hebei Medical University
Apr 27, 2017
Non-Hodgkin's Lymphoma, B-cell Lymphoma Trial in Sutton (bevacizumab, Rituximab)
Terminated
- Non-Hodgkin's Lymphoma
- B-cell Lymphoma
- bevacizumab, Rituximab
-
Sutton, Surrey, United Kingdom
- +1 more
Oct 13, 2016
B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Philadelphia (Bexxar)
Completed
- B-cell Lymphoma
- Non-Hodgkin's Lymphoma
-
Philadelphia, PennsylvaniaAbramson Cancer Center, University of Pennsylvania
Aug 15, 2016
B-Cell Lymphoma Trial in New Haven (Clofarabine)
Completed
- B-Cell Lymphoma
-
New Haven, ConnecticutYale Comprehensive Cancer Center at Yale University School of Me
Jan 28, 2015
Non-Hodgkin's Lymphoma, B-cell Lymphoma Trial in San Francisco (Velcade (bortezomib), rituximab, ifosfamide, carboplatin,
Terminated
- Non-Hodgkin's Lymphoma
- B-cell Lymphoma
- Velcade (bortezomib), rituximab, ifosfamide, carboplatin, etoposide
-
San Francisco, CaliforniaUnviersity of California Medical Center
Sep 24, 2012
B-Cell Lymphoma Trial in New York, Villejuif, Sheffield (half cyclophosphamide, without COPADM3, mini CYVE, without 3
Completed
- B-Cell Lymphoma
- half cyclophosphamide
- +4 more
-
New York, New York
- +2 more
Mar 27, 2012
B-Cell Lymphoma, Hodgkin's Disease Trial in Atlanta (Thalidomide)
Terminated
- B-Cell Lymphoma
- Hodgkin's Disease
-
Atlanta, GeorgiaEmory University Winship Cancer Institute
May 6, 2009
B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)
Completed
- B-Cell Lymphoma
- +2 more
- VELCADE and rituximab
-
Los Angeles, California
- +12 more
Feb 7, 2008
B-Cell Lymphoma Trial in Belgium, France, Switzerland (Zevalin plus BEAM)
Completed
- B-Cell Lymphoma
- Zevalin plus BEAM
-
Mont-Godinne, Belgium
- +8 more
Sep 6, 2006